Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns

Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Merkel cell carcinoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Merkel cell carcinoma patients.

NCT Number	NCT06039033
Lead Sponsor	Power Life Sciences Inc.
Conditions	Merkel Cell Carcinoma
Enrollment	500 participants
Start Date	2024-10
Primary Completion	2025-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2023-09-15